Showing posts with label PrEP. Show all posts
Showing posts with label PrEP. Show all posts

Thursday, December 1, 2011

[VIDEO] PrEP Talk with Dr. Kimberly Smith Pt. 3

The following video interview comes from Dr. Kimberly Y. Smith, who is an infectious disease specialist at RUSH University Medical Center; in the following clip Dr. Smith discusses the promise of pre-exposure prophylaxis (PrEP), recommendations for use, and potential challenges.

We encourage others to share their experiences, thoughts, concerns, or questions they may have about PrEP and HIV prevention strategies here on LifeLube. Again we encourage all to share your perspectives at myprepexperience@gmail.com!




See the video here too

Click here to pull up all the My PrEP Experience stories posted on LifeLube, including video and written testimonials, from other people sharing their PrEP* experiences. Please feel free to share your reactions in the comments section. And if you have used PrEP, we invite you to share your PrEP experience by video, or in writing. Why did you make the decision to use PrEP? What were some of the challenges you faced in making this decision? How is taking PrEP working out for you? How has it impacted your life? Send video or audio links and/or text to myprepexperience@gmail.com and we will post them here, on LifeLube.  You can include your name, or you may contribute to My PrEP Experience anonymously. Your voice is important!  Please consider sharing your personal experience with PrEP at My PrEP Experience

[VIDEO] PrEP Talk with Dr. Kimberly Smith Pt. 2

The following video interview comes from Dr. Kimberly Y. Smith, who is an infectious disease specialist at RUSH University Medical Center; in the following clip Dr. Smith discusses the promise of pre-exposure prophylaxis (PrEP), recommendations for use, and potential challenges.

We encourage others to share their experiences, thoughts, concerns, or questions they may have about PrEP and HIV prevention strategies here on LifeLube. Again we encourage all to share your perspectives at myprepexperience@gmail.com!




See the video here too

Click here to pull up all the My PrEP Experience stories posted on LifeLube, including video and written testimonials, from other people sharing their PrEP* experiences. Please feel free to share your reactions in the comments section. And if you have used PrEP, we invite you to share your PrEP experience by video, or in writing. Why did you make the decision to use PrEP? What were some of the challenges you faced in making this decision? How is taking PrEP working out for you? How has it impacted your life? Send video or audio links and/or text to myprepexperience@gmail.com and we will post them here, on LifeLube.  You can include your name, or you may contribute to My PrEP Experience anonymously. Your voice is important!  Please consider sharing your personal experience with PrEP at My PrEP Experience.

[VIDEO] PrEP Talk with Dr. Kimberly Smith Pt. 1

The following video interview comes from Dr. Kimberly Y. Smith, who is an infectious disease specialist at RUSH University Medical Center; in the following clip Dr. Smith discusses the promise of pre-exposure prophylaxis (PrEP), recommendations for use, and potential challenges.

We encourage others to share their experiences, thoughts, concerns, or questions they may have about PrEP and HIV prevention strategies here on LifeLube. Again we encourage all to share your perspectives at myprepexperience@gmail.com!




See video here too
Click here to pull up all the My PrEP Experience stories posted on LifeLube, including video and written testimonials, from other people sharing their PrEP* experiences. Please feel free to share your reactions in the comments section. And if you have used PrEP, we invite you to share your PrEP experience by video, or in writing. Why did you make the decision to use PrEP? What were some of the challenges you faced in making this decision? How is taking PrEP working out for you? How has it impacted your life? Send video or audio links and/or text to myprepexperience@gmail.com and we will post them here, on LifeLube.  You can include your name, or you may contribute to My PrEP Experience anonymously. Your voice is important!  Please consider sharing your personal experience with PrEP at My PrEP Experience.


Wednesday, November 30, 2011

Empowering Young, Black, Gay Men for HIV Prevention

via HuffPost Gay Voices, by Charles Stevens

The most recent statistics indicate that an entire generation is being impacted by HIV on an epic scale.

HIV cases among young, black, gay and bisexual men increased to an estimated 48 percent between 2006 and 2009, according to new data from the U.S. Centers for Disease Control and Prevention (CDC).

Ultimately, it is impossible to discuss HIV/AIDS in the black community without addressing the importance of tolerance.

It is up to us -- relatives, co-workers and friends -- to engage our black, gay brothers in a conversation that is constructive and rooted in concern, one that turns to them for insight instead of turning them away.

There have been significant political and medical advances made in HIV/AIDS prevention.

The National AIDS Strategy, a key achievement of Barack Obama's presidency, is a prime example. By focusing with laser precision on at-risk groups and prioritizing addressing disparities in HIV, there will be historic gains.

On the scientific front, advances in biomedical HIV-prevention tools, such as pre-exposure prophylaxis, or PrEP, have given us signs of hope even as we take a collective gasp at the work ahead of us.

However, HIV has never been merely a public health issue but a social one, as well. It is an issue that impacts us not only abstractly but also in a very real and tangible way.

The black community as a whole has made substantial progress, more than is credited, in terms of embracing our diversity. Many unsung heroes and heroines have taken great strides in challenging anti-gay attitudes.

Straight allies have also spoken out unapologetically in support of their gay brethren. However, there is still work to do, and HIV/AIDS makes building bridges across orientations even more critical.

The black community has just as much of an incentive to be a part of the solution: the "win" is the lives of our people, the lives of young, black, gay men. These men are valued; their lives are priceless. They are assets to our communities.


Read the rest

Friday, November 11, 2011

U.S. Conference on AIDS

via Windy City Times, by Kate Sosin

The U.S. Conference on AIDS, held this year in Chicago for the first time, opened with a welcoming plenary breakfast that featured major names in HIV/AIDS prevention.

Secretary Kathleen Sebelius of the Department of Health and Human Services headlined the morning.
 
But the moment that left many talking later in the day was a protest that interrupted the introduction of Sebelius. As Sebelius was announced with much fanfare, a large group of protesters with posters marched out and stole the microphone.
 
The group, protesting on behalf of Asian Pacific Islanders, demanded that their voices be heard in HIV prevention. They came bearing signs that read "Our Lives Matter."
 
"We cannot to wait," said Sharon Day of the Indigenous Peoples Task Force. "We, the first Americans, can no longer be the last in line for funding."
 
In what appeared to be a last-minute switch, National AIDS Policy Director Jeff Crowley took the stage in place of Sebelius. Crowley had been scheduled to speak later in the program.
 
Crowley challenged HIV service providers to adapt to healthcare changes and medical advancements to end AIDS. He called for focus and unity from AIDS organizations as pre-exposure prophylaxis (taking HIV meds to prevent becoming infected with HIV) is now a tool on the horizon.
 
"That is great news but right now it's a research study," said Crowley, who pressed providers to think realistically about how new science can be used to end HIV/AIDS. "I would ask all of you in this time of fundamental change to really seize the moment."
 
Protesters appeared a second time as Sebelius attempted to take the stage. She acknowledged the group before they sat down.
 
According to staffers for the National Minority AIDS Council, the organization that hosts the annual conference, organizers had anticipated the protest, although the last-minute swap of presenters appeared to be unscripted.
 
Sebelius spoke of the Obama administration's commitment to ending AIDS. She said the president had requested $50 million in additional funds for the AIDS Drug Assistance Program, which currently suffers from lack of funds, leaving thousands on a waiting list for HIV/AIDS treatment.
 
Despite the implementation of the Affordable Care Act, which will provide health insurance to Americans by 2014, Sebelius said that the administration remains committed to Ryan White funding (that money has funded HIV/AIDS treatment for patients without insurance who cannot afford to pay).
 
The secretary added that her department is working to reallocate funding to communities considered high-risk currently.
 
Sebelius echoed the sentiments of many at the conference, who argue that the current moment is critical for mobilizing to end AIDS. Experts say that given new advances in science, an end to the virus is on the horizon, but those advancements have also led to apathy as the those who contract HIV and get treatment can live healthier and longer lives than ever before.
 
Further, significant funding increases are needed if those treatments are to be implemented.
 
"We have some very important questions to ask ourselves today," Sebelius said. "What will we do with this opportunity … will we watch HIV/AIDS further recede from the national spotlight?"
 
In a special press conference after her appearance, Sebelius reaffirmed her commitment to Ryan White funding, stating that those funds will now fill "cracks in the system, not gaping holes." She also commented on the morning's protest.
 
"They were saying 'our lives matter,' and my response is, you bet they do," she said.
Thousands attended the breakfast, the first of four days of conference events.
 
David Ernesto Munar, president of the AIDS Foundation of Chicago, welcomed the conference on behalf of the host committee.
 
Munar encouraged conference attendees to adopt a Chicago attitude while in town.
 
"Chicagoans are a roll up your sleeves kind of people," Munar said. "I hope the hardy spirit of Chicago rubs off on you," because, he said, there is much work to be done to end AIDS.


See the rest

Monday, November 7, 2011

Most UK Gay Men accept PrEP!

via aidsmap, by Roger Pebody

While few gay men in England are currently aware of pre-exposure prophylaxis (PrEP), most men who are introduced to the idea support PrEP being made available.

Half would consider taking it themselves, but most would prefer to take it on a daily basis, rather than before and after each time they have sex. These findings come from a snapshot survey of gay men in England, published by Sigma Research this week.

Pre-exposure prophylaxis (PrEP) involves HIV-negative people taking anti-HIV drugs in order to reduce their risk of infection. Results of the iPrEX study into the safety and effectiveness of PrEP in gay and other men who have sex with men showed that, overall, it reduced infections by 43%. Much higher levels of efficacy were seen in men with good adherence to PrEP.

Recent studies with American gay men have shown that while only a minority of men is aware of PrEP, a majority would consider using it.

Most men say PrEP would not affect their own use of condoms, particularly if it is only partially effective.

To investigate the views of gay men in England, researchers put a series of questions to members of the Sigma Panel in June 2011.

The panel is made up of approximately 1500 gay men, bisexual men and other men that have sex with men (MSM) who respond to monthly cross-sectional online surveys about HIV and sexual health.

The surveys have a short turnaround for analysis and reporting to health workers.

Only men who do not have diagnosed HIV were asked about PrEP; 1259 responded.

Prior awareness of PrEP was low. Only 17% of respondents said that they had already heard of the idea of taking a pill before sex in order to prevent HIV infection.

Having informed respondents about what PrEP is and how it might be prescribed, the researchers asked whether men would consider using PrEP, should they be offered it at a sexual health clinic.

Just over half (52%) said they would consider it, while 30% weren’t sure and 17% wouldn’t consider taking PrEP.

There were no differences in the proportion who would consider its use by age, education or sexual identity. Men who had casual partners were slightly more likely to consider its use.

Men who had a regular sexual partner who was HIV-positive were no more likely to consider PrEP than others.

Men who would consider using PrEP were asked why. Generally they wished to avoid HIV infection and believed that PrEP could help reduce this risk.

Many of these men saw PrEP as providing “additional protection”; this could help bring peace of mind.

Some men who use condoms all the time expressed an interest in taking PrEP.


Tuesday, October 25, 2011

Don't Delay HIV Prevention for Gay and Bi Men

by David Ernesto Munar, via HuffPo

Lives will be saved when the Food and Drug Administration puts its stamp of approval on a groundbreaking preventative approach called pre-exposure prophylaxis, or PrEP, recently found to reduce HIV infections.

With PrEP, people who are not infected with HIV take a daily pill, usually used to treat the disease, to help prevent infection -- as part of a broad HIV
prevention approach that includes condoms and safer-sex counseling.

But the longer the FDA waits before beginning its review of the HIV medication Truvada for prevention, the more lives will be unnecessarily lost. This is particularly true for those at greatest risk: gay and bisexual men.

We urge the FDA to immediately begin its review for approval of Truvada for PrEP for gay and bisexual men.

Read the rest.


Wednesday, October 19, 2011

HIV/AIDS Organizations Tell FDA and Gilead Sciences: Don’t Delay HIV Prevention for Gay and Bisexual Men and Transgender Women

[Press Release - October 18, 2011]

Thirteen prominent U.S. HIV/AIDS organizations have issued an open letter to the U.S. Food and Drug Administration and Gilead Sciences calling for prompt regulatory review of pre-exposure prophylaxis (PrEP) for HIV prevention in gay and bisexual men and transgender women (men who have sex with men, or MSM). The letter urges FDA and Gilead to start the review process that could allow safe and appropriate approved PrEP use as a public health intervention, and not to delay review because of distinct questions about the safety and efficacy of PrEP in heterosexual populations.

[The letter is available online here. LifeLube's mother - AIDS Foundation of Chicago - is a signatory.]

Pre-exposure prophylaxis, or PrEP, is a new HIV prevention method in which an uninfected person takes a daily HIV medication to reduce HIV infection risk. Data from an international study released in November, 2010 called iPrEx found that men and transgender women who have sex with men who received a daily single-tablet dose of the HIV drugs tenofovir and emtricitabine along with condoms and safe sex counseling had an average of 42% fewer HIV infections than those who received condoms and counseling alone.

Advocates assert that the need for new HIV prevention strategies for MSM is urgent. The U.S. Centers for Disease Control (CDC) estimates that MSM account for more than half of all new HIV infections in the United States. CDC logged an estimated 34% increase in HIV infections in young gay men between 2006 and 2009, and a 48% HIV increase among young black/African American gay men over the same period.

“We desperately need new strategies and tools to reduce the rapidly increasing rates of HIV infection in black gay and bisexual men,” said Phill Wilson, executive director of the Black AIDS Institute. “We’ve had evidence of PrEP’s effectiveness in MSM for almost a year now. It’s time to use every tool at our disposal to reduce the 50,000 new HIV infections that occur each year in this country. Prompt FDA review will help ensure that appropriate guidelines for PrEP use are established that can reduce HIV infections and safeguard public health.”

Data on PrEP in heterosexuals raise important but unique questions that may require further study. Two major trials in Africa found that PrEP reduces HIV infection risk in heterosexual men and women substantially. But two other studies present conflicting information about how PrEP works in heterosexuals. Critical and necessary efforts to understand how PrEP interacts with hormonal contraception, or how PrEP may impact pregnancy, however, should not delay access to a potentially lifesaving form of HIV prevention for MSM.

Before the results of the heterosexual PrEP studies were announced, the FDA and Gilead Sciences, the maker of the drugs, were reported to be ready to move quickly to consider approval of PrEP for those MSM who could benefit from the approach. Recent signs indicate, however, that FDA review of PrEP for this population may not start until the agency acquires more data on PrEP among heterosexuals—despite the urgent need for new HIV prevention strategies for MSM, and the fact that PrEP data in MSM were announced nearly one year ago.

“The FDA and Gilead Sciences should move quickly to ensure a thorough review of PrEP for MSM now, while they both work simultaneously and swiftly to thoroughly address questions and concerns about PrEP among heterosexual populations,” said Mitchell Warren, executive director of AVAC “Prompt FDA review of PrEP in MSM is the right thing to do for public health. In the midst of a growing HIV epidemic, HIV prevention delayed is HIV prevention denied.”

Thursday, September 8, 2011

SF First U.S. City to Provide Anti-HIV Pill to Gay Men (natch)

via Bay Area Reporter, by Matthew S. Bajko

San Francisco is expected to become the first city in the country to offer gay men an anti-HIV pill that has proven successful in stopping transmission of the virus that causes AIDS.

Officials with the National Institutes of Health and San Francisco public health officials are close to finalizing an agreement to launch in early 2012 a demonstration project for usage of pre-exposure prophylaxis or PrEP. The combination pill contains tenofovir and emtricitabine (Gilead Science's Truvada) and has proven to be highly effective during clinical trials studying its efficacy.

Under the contract, up to 300 men who have sex with men at high risk for contracting HIV would be enrolled in the pilot study. City Clinic would administer the program while Magnet, the gay men's health center in the Castro, would help identify suitable participants for the study.

"We are anticipating we will be the first municipality to implement a PrEP demonstration project and things are moving forward toward that goal," Dr. Grant Colfax, the city's director of HIV prevention, told the Bay Area Reporter this week. "We are hoping the demo project would be implemented in the first quarter of 2012."


Read the rest.


Wednesday, September 7, 2011

My PrEP Experience - Leo from NYC tells his story

by Leo, NYC

I am a 47 year old gay white male who began using Prep (Truvada) about 4 months ago, in April 2011. (That's my dog on the left.)

My medical doctor suggested that based on frequent sexual encounters (mostly hooking up with men from Manhunt and Adam for Adam) that I should take the medication.

I tested negative for HIV when I started taking the medication. I have not had any side effects from taking the medication. My insurance company is currently covering the cost (I have a $50 co-pay).

I have had sex without condoms on many occasions since I began taking the medication (anal sex both as a top and bottom). Before I have sex with a guy I do ask his HIV status. I have not been using condoms only with guys who say they are negative ( although I think at least one of the guys was positive). I do not cum inside anyone and I do not let anyone cum inside of me. Also if I notice that the guy that I am with has a lot of pre-cum I make him wear a condom if I am going to bottom.

I have been testing myself every month (I order the test kits on line...its cheaper than going to the doctor) since I began using the medication and I have tested negative each time.

I last tested negative on August 27, 2011.


Click here to pull up all the My PrEP Experience stories posted on LifeLube, including video and written testimonials, from other people sharing their PrEP* experiences. Please feel free to share your reactions in the comments section. And if you have used PrEP, we invite you to share your PrEP experience by video, or in writing. Why did you make the decision to use PrEP? What were some of the challenges you faced in making this decision? How is taking PrEP working out for you? How has it impacted your life? Send video or audio links and/or text to myprepexperience@gmail.com and we will post them here, on LifeLube.  You can include your name, or you may contribute to My PrEP Experience anonymously. Your voice is important!  Please consider sharing your personal experience with PrEP at My PrEP Experience.


Tuesday, August 23, 2011

My PrEP Experience - Check out Benjamin's Personal PrEP Story

This is a real story from Benjamin - the fourth in an ongoing series on LifeLube - from someone who has chosen to use PrEP* as one way to protect himself from HIV.

Click here to pull up all the My PrEP Experience stories posted on LifeLube to date, including video, audio, and written testimonials, from other people sharing their PrEP experiences.






Please feel free to share your reactions to Benjamin's story in the comments section.

And if you have used PrEP, or are using PrEP, we invite you to share your PrEP experience by video, audio, or in writing.

Why did you make the decision to use PrEP? What were some of the challenges you faced in making this decision? How is taking PrEP working out for you? How has it impacted your life?

Send video or audio links and/or text to myprepexperience@gmail.com and we will post them here, on LifeLube.  You can include your name, or you may contribute to My PrEP Experience anonymously.

Your voice is important!  Please consider sharing your personal experience with PrEP at My PrEP Experience.
*Pre-Exposure Prophylaxis, or PrEP, is a new HIV prevention strategy in which HIV-negative people use HIV antiretrovirals (ARVs), drugs usually used to treat HIV infection, to reduce their risk of becoming infected with HIV. Trials among gay men, other men who have sex with men as well as heterosexuals,have shown that PrEP can reduce HIV infection risk – especially when PrEP is taken consistently, and if condoms and other safer sex strategies are used as well. Another study is now underway to test if PrEP works among injection drug users with results expected in 2012.
For more information on PrEP and other new prevention technologies, visit AVAC.org. To learn about rectal microbicides – new prevention technologies that could be delivered via lubricants or rectal douches for people who engage in anal intercourse, visit IRMA – International Rectal Microbicide Advocates.
Click here to pull up all the My PrEP Experience posts, including video and written testimonials.

And click here for the My PrEP Experience YouTube channel.

Monday, August 15, 2011

My PrEP Experience - Nick Literski Hasn't Given Up, He's Taken Charge

by Nick Literski, Seattle [this powerful personal testimonial has been featured on LifeLube previously, and is being highlighted again as part of our My PrEP Experience series.]

Click here to pull up all the My PrEP Experience stories posted on LifeLube, including video and written testimonials, from other people sharing their PrEP* experiences. Please feel free to share your reactions in the comments section. And if you have used PrEP, we invite you to share your PrEP experience by video, or in writing. Why did you make the decision to use PrEP? What were some of the challenges you faced in making this decision? How is taking PrEP working out for you? How has it impacted your life? Send video or audio links and/or text to myprepexperience@gmail.com and we will post them here, on LifeLube.  You can include your name, or you may contribute to My PrEP Experience anonymously.

Your voice is important!  Please consider
sharing your personal experience with PrEP at My PrEP Experience.

Recently, I was surprised to learn that I had allegedly “given up on gay men.”

According to Michael Weinstein, president and founder of the so-called “AIDS Healthcare Foundation,” I now consider the lives of gay men, including myself, “disposable.” What great crime have I committed to deserve Mr. Weinstein’s condemnation? I take Truvada once a day, as pre-exposure prophylaxis (PrEP), in order to protect myself from HIV infection.

My partner and I have a mutually open relationship. In reaching that point, we did the responsible things that a new couple should do to protect themselves. We used condoms until we’d been together long enough to rely on HIV testing. We then chose to be fluid bonded, while always playing “safe” with other sexual partners. Every six months, we were both dutifully tested for the HIV virus, usually going to the local testing facility together. We were screened on a regular basis for other sexually transmitted infections. If we made a mistake with regard to our agreed precautions (and yes, I did so on at least one occasion) we were honest with each other.

About two years into our relationship, we were surprised to hear that my partner’s HIV test was “inconclusive,” and that the testing facility would be submitting it for further testing. A week later, we called back for the final report, and were relieved when an obviously hurried staffer told my partner he was “just fine.” We continued our very active sex life, which almost always involved me being the receptive partner in anal intercourse. During the next few months, however, my normally robust partner had an unusual number of illnesses, particularly skin infections. He became suspicious, and since we were nearly due for our six month testing anyway, he scheduled another test.

As I sat in the waiting area, I received a two word text from my partner: “I’m positive.”

To make matters worse, the staffer had pulled my partner’s chart, and found that his last “inconclusive” test had actually been positive. Due to the mistake of a careless (former) staffer, we had received an incorrect report.

As traumatizing as it was for my partner to find out that he was HIV positive, and as angry as he was about the earlier false report, he was truly terrified that he had exposed me to the virus innumerable times over the past several months. I was promptly tested, and we were relieved to learn that both my rapid testing and RNA results were negative.

Even so, my partner continued to experience tremendous anxiety over the possibility of infecting someone he loved. His worry extended to all sorts of seemingly-mundane possibilities, even to the point of not wanting me to share the same handle on our interchangeable-head electric toothbrush. While it’s normal for newly-seroconverted men to experience high levels of anxiety regarding sex, the impact on our intimate life was profound. My partner had experienced enough broken condom incidents over the years that his concerns weren’t alleviated by using them. At the same time, it was difficult for me to adapt to continuous condom use, due to both physical discomfort and my own emotional response to a physical barrier. Sex became much less frequent, and was burdened by worry and frustration.

In time, and with the help of an outstanding physician, my partner’s viral load became undetectable. In the meantime, both of us had educated ourselves on HIV. We knew that a Swiss study indicated that the risk of my being infected by my partner was now extremely low (due to his undetectable viral load), even to the point that some physicians in Switzerland believed protection was unnecessary.

My partner was able to relax more, and we began to settle into the “new normal” of being a serodiscordant couple.Even at this stage, however, there were emotional challenges.

I still hated using condoms, and I still wanted to feel my partner inside me.

I felt the risk was low enough to be acceptable, and a selfish part of me wanted to be the one making the decision on whether to use protection. Another part of me knew, deep down, that by encouraging unprotected sex with my partner, I wasn’t giving my partner’s emotional well-being the importance he deserved. All too often, I placed my partner in the difficult position of wanting to protect me from infection, while at the same time wanting to satisfy my desire for sex without physical barriers. When my partner gave in to my preference, he generally pulled out before ejaculating, but afterward he dealt with understandable worry. The combination of anxiety and infrequency continued to wear on our relationship.

Somewhere in the midst of all this, I reached a state of mind that seems almost universal among HIV negative partners of HIV positive men.

As low as the risk of infection seemed to be, I still had a nagging worry that I might become positive.

I hated using condoms. I hated seeing my partner constantly worry about infecting me. I worried that my partner would grow so tired of that worry that he might choose to leave the relationship in pursuit of an HIV positive partner. I resented that at times, my partner seemed more comfortable having sex with another HIV positive man than with me. None of these feelings were particularly rational, but they existed.

In keeping with that irrationality, I felt what so many HIV negative men in serodiscordant relationships feel. In a very real sense, part of me wished that I would become infected, just so the whole issue would “go away.” What seemed like a “manageable condition” with new medications seemed preferable to the ongoing stress and frustration. In time, and with seeing the physical problems my partner suffered as a result of his HIV infection, I got past that stage. Unfortunately, many HIV negative men in serodiscordant relationships seem to go through that stage, and some don’t to their senses before permanently affecting their health.

We gradually settled into a “serodiscordant detente,” in which my partner reluctantly agreed that it was up to me whether I wanted to take the risks inherent in unprotected sex, but he almost always pulled out before ejaculation.

At times, I selfishly prevented the latter from happening, not considering the stress I was causing him. There was no simple solution, so while we could still have great sex, it was always accompanied by some level of anxiety and guilt. We were handling it imperfectly, but perhaps the best we could at the time.

Then came November of 2010, and the New England Journal of Medicine’s publication of a study showing the effectiveness of PrEP for men who have sex with men. Our physician, a true expert in the field of HIV prevention and treatment, was familiar with the study prior to its publication. Once results were published, he had a frank discussion with my partner about our sexual activities (something like “Don’t lie to me, I have a really big needle that I can jab you with if you’re lying”). Because we have a great deal of trust in our doctor, my partner was honest with him about our behaviors. Based on that discussion, our doctor asked me to visit him and discuss the possibility of taking PrEP. I made an appointment for a week later.

In the meantime, I agonized over the issue. I searched the Internet and read everything I could find on the subject, both for and against PrEP. In particular, I carefully read the actual study report in the New England Journal of Medicine. I made notes of the questions raised in my mind, and brought them with me when I visited my doctor. We discussed my questions thoroughly, along with the fact that I already had a recent HIV test establishing that I was still negative. My doctor outlined the requirement that I would take the medication every day as directed, and that he would test me for kidney function and other potential side effects on a regular basis. In the end, I decided that the benefits outweighed the risks, and I chose to begin taking Truvada.

The cost of PrEP is naturally a major factor. My physician informed me that several insurance companies were actively considering coverage of PrEP, knowing that it was much less expensive than treatment of an HIV positive patient. Fortunately, my health insurance company had already chosen to cover PrEP, and I’ve never had a problem obtaining Truvada with a reasonable copay.

Perhaps the second most common question I’m asked is whether I’ve had side effects from using PrEP. It’s true that for some men, Truvada can cause nausea or diarrhea (usually only for the first month of use), or even kidney damage. I’m pleased to say that I haven’t experienced such problems. I take my medication every night. The first morning after I began taking Truvada, I had some very minor diarrhea, but this has never recurred, so it may have been entirely coincidental. True to his word, my physician has insisted on regular tests to monitor my kidney function, HIV status, and other health measures. My test results have been entirely normal.

In fact, the only “side effect” I’ve experienced while using PrEP is frustration over the anti-PrEP propaganda efforts of Michael Weinstein and his AIDS Healthcare Foundation.

I’ve read a great deal of the material issued by Mr. Weinstein, and I recently participated with him in a public forum on the use of PrEP, along with several committed advocates of HIV prevention. Where experts presented factual data regarding PrEP, Mr. Weinstein attempted to inspire fear of PrEP, and advocate against the makers of Truvada. Mr. Weinstein’s fear-mongering should come as no surprise, given that he previously attempted to sue the makers of Viagra, claiming that the erectile dysfunction drug contributed to the spread of HIV.

Mr. Weinstein consistently misrepresents the study data. First, he claims that PrEP only proved to be 44% effective in preventing HIV infection. He avoids stating that closer examination of the study results shows that those in the study group who became infected with HIV were found to have no Truvada in their bloodstream, or only trace levels. In other words, the infected individuals failed to actually take Truvada daily as directed. None of the men who were found to actually be taking Truvada on a daily basis throughout the study became infected with HIV.

Second, Mr. Weinstein complains that the study wasn’t “real world,” because those enrolled received monthly prevention counseling and health monitoring. To Mr. Weinstein, it was really the counseling that prevented infection, rather than PrEP. What Mr. Weinstein fails to recognize is that all study participants, including those taking a placebo, were given the same counseling and monitoring. In other words, the controlled study took this factor into account, so that the use of PrEP would truly be the only difference between the groups. When the study reports that PrEP was effective in reducing HIV infections, it reflects a situation in which all other factors were equal. For the men taking placebo, counseling alone didn’t protect them from HIV infection.

Perhaps knowing that consistent, daily use of PrEP really did prevent HIV infection, Mr. Weinstein insists that gay men cannot be relied upon to take Truvada daily. Mr. Weinstein doesn’t explain why he believes that the same men who can’t be trusted to take a pill every day can be expected to use a condom every time they have sex (the only prevention method he seems to approve).

My own anecdotal experience contradicts Mr. Weinstein’s theory. I take my Truvada every night before bed. In the five months I’ve been taking the drug, I’ve forgotten only once, and I took it the following morning, making it a “late” dose, rather than a “missed” dose. I’m not always the most responsible person on the planet, but I take my medication as directed, because I realize that as part of a serodiscordant relationship, I have a comparatively high risk of infection. I take my medication as directed, because I have an excellent physician who reminds me about how important that is.

I take my medication as directed, because I love my partner, and knowing that I take PrEP daily helps reduce his worry and stress.

Mr. Weinstein complains that the availability of PrEP will make men less likely to use condoms, thus making them less protected against HIV infection. While I can’t deny that this may occur for some men, my own experience reflects quite differently. While my partner has an undetectable viral load, resulting in a less than 1% chance of him infecting me, that chance continues to exist. Before PrEP became available, I was taking a calculated risk with my partner, because even with counseling from my trusted physician, physical comfort and intimacy without barriers were ultimately more important to me than further reducing that tiny 1%. My physician, having directly asked about this, determined that I was a good candidate for a method that would overcome those objections.

PrEP didn’t make me stop using condoms.

Instead PrEP provided me with protection that I would use consistently, rather than protection that I was already rejecting. With PrEP, that 1% risk of infection from my partner’s undetectable viral load has been further reduced by my own level of personal protection (92% for those who use PrEP daily).

In the end, my belief that the benefits of PrEP would outweigh the risks has proven true for me. I’m carefully monitored to ensure that I don’t develop harmful side effects. I comply with the treatment regimen faithfully. My insurance covers the medication. My overall level of protection against HIV infection has increased dramatically. Just as importantly, however, PrEP has made a real difference in my relationship with my partner. We’re able to be intimate in a way both of us prefer, without the fears and conflicting feelings that were present even with condoms.

I haven’t “given up on gay men,” or deemed my life “disposable.”

Rather, I’ve made a responsible health choice that works for me, and I’m happy with it.

*Pre-Exposure Prophylaxis, or PrEP, is a new HIV prevention strategy in which HIV-negative people use HIV antiretrovirals (ARVs), drugs usually used to treat HIV infection, to reduce their risk of becoming infected with HIV. Trials among gay men, other men who have sex with men as well as heterosexuals,have shown that PrEP can reduce HIV infection risk – especially when PrEP is taken consistently, and if condoms and other safer sex strategies are used as well. Another study is now underway to test if PrEP works among injection drug users with results expected in 2012.
For more information on PrEP and other new prevention technologies, visit AVAC.org. To learn about rectal microbicides – new prevention technologies that could be delivered via lubricants or rectal douches for people who engage in anal intercourse, visit IRMA – International Rectal Microbicide Advocates.
Click here to pull up all the My PrEP Experience posts, including video and written testimonials.

And click here for the My PrEP Experience YouTube channel.

Thursday, August 11, 2011

Hear from Brian - My PrEP Experience

This is a real story - the second in an ongoing series - from someone who has chosen to use PrEP* as one way to protect himself from HIV.

Click here to pull up all the My PrEP Experience stories posted on LifeLube to date, including video and written testimonials, from other people sharing their PrEP experiences.




Please feel free to share your reactions in the comments section.

And if you have used PrEP, we invite you to share your PrEP experience by video, or in writing. Why did you make the decision to use PrEP? What were some of the challenges you faced in making this decision? How is taking PrEP working out for you? How has it impacted your life? Send video or audio links and/or text to myprepexperience@gmail.com and we will post them here, on LifeLube.  You can include your name, or you may contribute to My PrEP Experience anonymously.

Your voice is important!  Please consider sharing your personal experience with PrEP at My PrEP Experience.
*Pre-Exposure Prophylaxis, or PrEP, is a new HIV prevention strategy in which HIV-negative people use HIV antiretrovirals (ARVs), drugs usually used to treat HIV infection, to reduce their risk of becoming infected with HIV. Trials among gay men, other men who have sex with men as well as heterosexuals,have shown that PrEP can reduce HIV infection risk – especially when PrEP is taken consistently, and if condoms and other safer sex strategies are used as well. Another study is now underway to test if PrEP works among injection drug users with results expected in 2012.
For more information on PrEP and other new prevention technologies, visit AVAC.org. To learn about rectal microbicides – new prevention technologies that could be delivered via lubricants or rectal douches for people who engage in anal intercourse, visit IRMA – International Rectal Microbicide Advocates.
Click here to pull up all the My PrEP Experience posts, including video and written testimonials.

And click here for the My PrEP Experience YouTube channel.

Wednesday, August 10, 2011

Gay men weigh their risk behavior choices with PrEP

via AIDS Map, By Michael Carter

“PrEP offers much promise as the first biomedical intervention to have success in at-risk men who have sex with men,” comment the researchers.

They therefore undertook further analysis to see how likely the men who participated in the study were to use PrEP and if its availability would change their HIV risk behaviour.

They undertook a survey in December 2010, immediately following the release of the IPrEX results, using Facebook and Black Gay Chat to recruit participants. A total of 1155 gay and other men who have sex with men were recruited to the study.

Participants completed a questionnaire about their knowledge and willingness to use PrEP; perceptions of the risk of HIV infection from unprotected anal sex with or without PrEP; perceptions of sexual pleasure; and perception of likelihood to experience sexual pleasure with or without a condom and with or without PrEP.
The men had an average age of 33 years, 75% were white, and 51% reported unprotected anal sex at least once in the last twelve months.

The availability of PrEP did not alter the perception of the risk associated with HIV in the majority of men, regardless of whether they were the insertive (75%) or receptive (60%) partner in anal sex.

Three-quarters of men stated that the 44% efficacy of PrEP in the IPrEX study would not affect their use of condoms. However, 7% reported that they would use condoms less frequently.

Unprotected anal sex without a condom was perceived as very pleasurable by approximately 50% of respondents.

Read more. 


Tuesday, August 9, 2011

NEW on LifeLube: My PrEP Experience - Rico Herrera Shares His PrEP Story

This is a real story - the first in an ongoing series - from someone who has chosen to use PrEP* as one way to protect himself from HIV.

Click here to pull up all the My PrEP Experience stories posted on LifeLube, including video and written testimonials, from other people sharing their PrEP experiences.




Please feel free to share your reactions in the comments section.

And if you have used PrEP, we invite you to share your PrEP experience by video, or in writing. Why did you make the decision to use PrEP? What were some of the challenges you faced in making this decision? How is taking PrEP working out for you? How has it impacted your life? Send video or audio links and/or text to myprepexperience@gmail.com and we will post them here, on LifeLube.  You can include your name, or you may contribute to My PrEP Experience anonymously.

Your voice is important!  Please consider sharing your personal experience with PrEP at My PrEP Experience.
*Pre-Exposure Prophylaxis, or PrEP, is a new HIV prevention strategy in which HIV-negative people use HIV antiretrovirals (ARVs), drugs usually used to treat HIV infection, to reduce their risk of becoming infected with HIV. Trials among gay men, other men who have sex with men as well as heterosexuals,have shown that PrEP can reduce HIV infection risk – especially when PrEP is taken consistently, and if condoms and other safer sex strategies are used as well. Another study is now underway to test if PrEP works among injection drug users with results expected in 2012.
For more information on PrEP and other new prevention technologies, visit AVAC.org. To learn about rectal microbicides – new prevention technologies that could be delivered via lubricants or rectal douches for people who engage in anal intercourse, visit IRMA – International Rectal Microbicide Advocates.
Click here to pull up all the My PrEP Experience posts, including video and written testimonials.

And click here for the My PrEP Experience YouTube channel.


Monday, August 1, 2011

PrEPing for the end of the HIV/AIDS epidemic

 via The Madison Times, By Phil Wilson


We have reached a deciding moment. HIV is 100 percent preventable, including among some of our most at-risk populations: women, gay and bisexual men and young adults.  HIV is also 100 percent diagnosable and in many cases treatable.  Our prevention toolbox is now exploding with options. We now have the all of the tools needed to end the AIDS epidemic!

The promising new PrEP results arrive at a critical time.  Wednesday marked the one-year anniversary of the launch of the historic National HIV/AIDS Strategy, the nation’s first comprehensive roadmap for fighting the epidemic, and one that places the well-being of Black people front and center. We also have health-insurance reform to provide care to the least among us.

But the anniversary and this remarkable string of study results come during an economic downturn that has seen many people lose jobs and others slip through the proverbial “safety net”—losing health insurance, unemployment, and other benefits.  It also comes at the same time many states are cutting funding for HIV/AIDS-prevention programs and the AIDS Drug Assistance Program (ADAP).

So while we have the toolkit to end the epidemic, the question remains whether we have the political will to invest in using the tools strategically, effectively and compassionately.

Read more.

Saturday, July 30, 2011

PrEP Sign on Letter for HIV+ Gay, Bi Men - Support an Informed Debate Based on Facts!

Read the letter, and sign on here.

 The release of data from the iPrEx study of pre-exposure prophylaxis (PrEP) for HIV prevention in gay and bisexual men and transgender women has led to a good deal of debate about whether and how PrEP should be used.

Unfortunately, some of that debate has been fueled by misrepresentations of the study data and, perhaps more alarmingly, by groundless assertions that gay/bi men and other men who have sex with men (MSM) will misuse PrEP, spread drug resistance and act without regard to their health or the health of others if PrEP is made available. A paid ad campaign by the AIDS Healthcare Foundation running in gay papers across the country has contributed to spreading false ideas both about PrEP and about the commitment of gay/bi men to care for themselves and others. We reject those false assertions and want a full and factual discussion of the pros and cons of PrEP in our community.

Recently, two additional studies, Partners PrEP and the CDC's TDF2 study have confirmed the safety and efficacy of PrEP, this time in heterosexual women and men.

A small group of HIV positive gay/bi men who are committed to promoting safer sex and the open exchange of accurate information are circulating the following letter to help clarify the facts about PrEP, open up community discussion and make clear our belief that we are entitled to respect, accurate information and new HIV prevention tools.

This sign on letter is part of a broad array of advocacy activities being undertaken by the national PrEP Committee. Members of the PrEP Committee include individuals from a host of organizations working on PrEP and other new prevention technologies who meet regularly by phone and email to share information and strategize.  

For allies who are not HIV+ gay/bi men, you can learn more about this work and how to participateby sending an email to Jim Pickett at jpickett@aidschicago.org.

We encourage HIV+ gay/bi men who are allied in the fight against AIDS to help us clear the record about PrEP by signing on to this letter.

Read the letter, and sign on here.

Thursday, July 28, 2011

"Magic" Pills and Potions - Hocus Pocus or Plus Plus?

LifeLube's Jim Pickett was part of a forum on PrEP in Seattle a few months ago called "The Magic Pill?" hosted by our fabulous friends Gay City Health Project. The following videos cover his talk - slides PLUS live action. Enjoy :)





[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

HIV researcher plans new PrEP study

via Chelsea Now, By Sam Spokony

[One major factual error in that article: “The longest any HIV-negative person has taken PrEP in a clinical study is 12 weeks.” For example in iPrEx, average follow up was 14 months. Otherwise, a very informative article.]

Few methods of HIV prevention have been as promising, or as controversial, as pre-exposure prophylaxis (PrEP). After a history of underground practice and off-label prescriptions, the approach has recently begun to receive serious attention from researchers, policy makers and health care advocates.

Under the guidance of Dr. Roy Gulick (director of the Weill Cornell Medical College HIV Clinical Trials Unit), a new experiment called the NEXT (Novel Explorations of Therapeutics) PrEP Study will begin this fall. It will include 400 at-risk, HIV-negative gay men, and will take place over 48 weeks at 12 sites across the U.S. and Puerto Rico.

The NEXT PrEP Study will differ from iPrEx in that its primary experimental group will receive a daily regimen of the drug maraviroc (brand name Selzentry). The control group will receive Truvada, and two other experimental groups will receive combinations of maraviroc and either tenofovir or FTC (the two individual drugs that make up Truvada). A major goal of the study, along with testing the HIV-prevention efficacy of maraviroc, will be to gauge the side effects of the drug on participants.

“The longest any HIV-negative person has taken PrEP in a clinical study is 12 weeks,” Gulick told Chelsea Now in a July 23 phone interview [This is inaccurate. The guys in iPrEx, for instance, were followed about 14 months - LifeLube]. “Now, since this is a drug we’re giving to healthy people, the next step is exploring further to prove that it is both safe and tolerable for them.”

Read more.

Thursday, July 21, 2011

Drug study sees up to 92-percent cut in HIV risk among gays

via Google, By AFP

[ This article offers a good overview of the data behind studies around pre-exposure prophylaxis]

Volunteers who responded most to a cocktail of antiretroviral drugs in an HIV prevention trial among gay men had a reduced risk of 92 percent of being infected by the AIDS virus, researchers said on Wednesday.

They presented the work as a last-minute, or "late-breaker", contribution to the world forum on AIDS science in Rome.

The research looked at a group of men who took part in a major trial called iPrEx HIV Prevention Study.
iPrEx explored the idea that an uninfected person taking daily AIDS drugs could be shielded from the human immunodeficiency virus (HIV), a novel approach called pre-exposure prophylaxis, or PrEP.

The overall findings, published last November, found that use of a drug called Truvada reduced HIV infections by 44 percent compared with a dummy pill, also called a placebo.

The new study looked at a sub-set of men who had the highest concentrations of the drug in their blood -- a telltale that they had been highly disciplined about taking the pill and that their system had also absorbed it better.

Read more.
Related Posts Plugin for WordPress, Blogger...

select key words

2007 National HIV Prevention Conference 2009 National LGBTI Health Summit 2011 LGBTI Health Summit 2012 Gay Men's Health Summit 2012 International AIDS Conference ACT Up AIDS AIDS Foundation of Chicago Africa BUTT Bisexual Bisexual Health Summit Brian Mustanski Center on Halsted Charles Stephens Chicago Chicago Black Gay Men's Caucus Chicago Task Force on LGBT Substance Use and Abuse Chris Bartlett Coaching with Jake Congress David Halperin David Munar Dr. James Holsinger Dr. Jesus Ramirez-Valles Dr. Rafael Diaz Dr. Ron Stall ENDA Ed Negron Eric Rofes FTM Feast of Fun Feel the love... Friday is for Faeries Gay Men's Health Summit 2010 HCV HIV HIV care HIV drugs HIV negative HIV positive HIV prevention HIV stigma HIV strategic plan HIV testing HIV/AIDS HPV Howard Brown Health Center IML IRMA Illinois International AIDS Conference Jim Pickett LGBT LGBT adoption LGBT culture LGBT health LGBT rights LGBT seniors LGBT youth LGBTI community LGBTI culture LGBTI health LGBTI rights LGBTI spirituality LGV Leon Liberman LifeLube LifeLube forum LifeLube poll LifeLube subscription Lorenzo Herrera y Lozano Lymphogranuloma Venereum MRSA MSM Monday Morning Perk-Up National AIDS Strategy National Gay Men's Health Summit One Fey's Tale Peter Pointers Pistol Pete PnP PrEP President Barack Obama Presidential Campaign Project CRYSP Radical Faerie STD Senator Barack Obama Sister Glo Sisters of Perpetual Indulgence Susan Kingston Swiss declaration Ted Kerr Test Positive Aware Network The "Work-In" The 2009 Gay Men's Health Agenda Tony Valenzuela Trans Gynecology Access Program Trans and Intersex Association Trevor Hoppe Who's That Queer Woof Wednesday You Tube abstinence only activism advocacy african-american aging issues anal cancer anal carcinoma anal health anal sex andrew's anus athlete ball scene bareback porn barebacking bathhouses bears big bold and beautiful bisexuality black gay men black msm blood ban blood donor body image bottom chubby chaser circumcision civil rights civil union communication community organizing condoms crystal meth dating dating and mating with alan irgang depression disclosure discrimination domestic violence don't ask don't tell douche downlow drag queen emotional health exercise female condom fitness gay culture gay identity gay latino gay male sex gay marriage gay men gay men of color gay men's health gay pride gay rights gay rugby gay sex gay youth gender harm reduction hate crime health care health care reform health insurance hepatitis C hiv vaccine homophobia homosexuality hottie hotties how are you healthy? human rights humor hunk immigration international mr. leather internet intimacy leather community leathersex lifelube survey love lube lubricant masturbation mental health microbicides middle music negotiated safety nutrition oral sex physical health pleasure podcast policy politics poppers porn post-exposure prophylaxis prevention prostate prostate cancer public health public sex venues queer identity racism recovery rectal microbicides relationships religion research safe sex semen sero-adaptation sero-sorting seroguessing sex sexual abuse sexual addiction sexual health sexual orientation smoking social marketing spirituality stigma stonewall riots substance abuse treatment substance use suicide super-bug superinfection syphilis testicle self-examination testicular cancer testing top trans group blog transgender transgender day of remembrance transgendered transmen transphobia transsexual universal health care unsafe sex vaccines video violence viral load writers yoga youtube